Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of Neotrofin in treating the peripheral neuropathy that results from chemotherapy for cancer.

Phase 2

NeoTherapeutics